ICD-10-CM update effective October 1, 2024: 291 new codes, 3 deleted, 15 revised titles, 33 billable-status changes. Compared with FY2024 (April 1, 2024). Source: the official CDC order files.
Other ICD-10-CM releases: FY2027, FY2026, FY2024, FY2023 (April 1, 2023), FY2023, FY2022 (April 1, 2022), FY2022, FY2021 (January 1, 2021), FY2021, FY2020 (April 1, 2020), FY2020, FY2019, FY2018, FY2017.
Also in this release: ICD-10-PCS changes.
C81.0A Nodular lymphocyte predominant Hodgkin lymphoma, in remissionC81.1A Nodular sclerosis Hodgkin lymphoma, in remissionC81.2A Mixed cellularity Hodgkin lymphoma, in remissionC81.3A Lymphocyte depleted Hodgkin lymphoma, in remissionC81.4A Lymphocyte-rich Hodgkin lymphoma, in remissionC81.7A Other Hodgkin lymphoma, in remissionC81.9A Hodgkin lymphoma, unspecified, in remissionC82.0A Follicular lymphoma grade I, in remissionC82.1A Follicular lymphoma grade II, in remissionC82.2A Follicular lymphoma grade III, unspecified, in remissionC82.3A Follicular lymphoma grade IIIa, in remissionC82.4A Follicular lymphoma grade IIIb, in remissionC82.5A Diffuse follicle center lymphoma, in remissionC82.6A Cutaneous follicle center lymphoma, in remissionC82.8A Other types of follicular lymphoma, in remissionC82.9A Follicular lymphoma, unspecified, in remissionC83.0A Small cell B-cell lymphoma, in remissionC83.1A Mantle cell lymphoma, in remissionC83.390 Primary central nervous system lymphomaC83.398 Diffuse large B-cell lymphoma of other extranodal and solid organ sitesC83.3A Diffuse large B-cell lymphoma, in remissionC83.5A Lymphoblastic (diffuse) lymphoma, in remissionC83.7A Burkitt lymphoma, in remissionC83.8A Other non-follicular lymphoma, in remissionC83.9A Non-follicular (diffuse) lymphoma, unspecified, in remissionC84.0A Mycosis fungoides, in remissionC84.1A Sezary disease, in remissionC84.4A Peripheral T-cell lymphoma, not elsewhere classified, in remissionC84.6A Anaplastic large cell lymphoma, ALK-positive, in remissionC84.7B Anaplastic large cell lymphoma, ALK-negative, in remissionC84.AA Cutaneous T-cell lymphoma, unspecified, in remissionC84.ZA Other mature T/NK-cell lymphomas, in remissionC84.9A Mature T/NK-cell lymphomas, unspecified, in remissionC85.1A Unspecified B-cell lymphoma, in remissionC85.2A Mediastinal (thymic) large B-cell lymphoma, in remissionC85.8A Other specified types of non-Hodgkin lymphoma, in remissionC85.9A Non-Hodgkin lymphoma, unspecified, in remissionC86.00 Extranodal NK/T-cell lymphoma, nasal type not having achieved remissionC86.01 Extranodal NK/T-cell lymphoma, nasal type, in remissionC86.10 Hepatosplenic T-cell lymphoma not having achieved remissionC86.11 Hepatosplenic T-cell lymphoma, in remissionC86.20 Enteropathy-type (intestinal) T-cell lymphoma not having achieved remissionC86.21 Enteropathy-type (intestinal) T-cell lymphoma, in remissionC86.30 Subcutaneous panniculitis-like T-cell lymphoma not having achieved remissionC86.31 Subcutaneous panniculitis-like T-cell lymphoma, in remissionC86.40 Blastic NK-cell lymphoma not having achieved remissionC86.41 Blastic NK-cell lymphoma, in remissionC86.50 Angioimmunoblastic T-cell lymphoma not having achieved remissionC86.51 Angioimmunoblastic T-cell lymphoma, in remissionC86.60 Primary cutaneous CD30-positive T-cell proliferations not having achieved remissionC86.61 Primary cutaneous CD30-positive T-cell proliferations, in remissionC88.00 Waldenstrom macroglobulinemia not having achieved remissionC88.01 Waldenstrom macroglobulinemia, in remissionC88.20 Heavy chain disease not having achieved remissionC88.21 Heavy chain disease, in remissionC88.30 Immunoproliferative small intestinal disease not having achieved remissionC88.31 Immunoproliferative small intestinal disease, in remissionC88.40 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remissionC88.41 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remissionC88.80 Other malignant immunoproliferative diseases not having achieved remissionC88.81 Other malignant immunoproliferative diseases, in remissionC88.90 Malignant immunoproliferative disease, unspecified not having achieved remissionC88.91 Malignant immunoproliferative disease, unspecified, in remissionD61.03 Fanconi anemiaE10.A Type 1 diabetes mellitus, presymptomaticE10.A0 Type 1 diabetes mellitus, presymptomatic, unspecifiedE10.A1 Type 1 diabetes mellitus, presymptomatic, Stage 1E10.A2 Type 1 diabetes mellitus, presymptomatic, Stage 2E16.A Hypoglycemia levelE16.A1 Hypoglycemia level 1E16.A2 Hypoglycemia level 2E16.A3 Hypoglycemia level 3E34.00 Carcinoid syndrome, unspecifiedE34.01 Carcinoid heart syndromeE34.09 Other carcinoid syndromeE66.81 Obesity classE66.811 Obesity, class 1E66.812 Obesity, class 2E66.813 Obesity, class 3E66.89 Other obesity not elsewhere classifiedE74.82 Disorders of citrate metabolismE74.820 SLC13A5 Citrate Transporter DisorderE74.829 Other disorders of citrate metabolismE88.82 Obesity due to disruption of MC4R pathwayF50.010 Anorexia nervosa, restricting type, mildF50.011 Anorexia nervosa, restricting type, moderateF50.012 Anorexia nervosa, restricting type, severeF50.013 Anorexia nervosa, restricting type, extremeF50.014 Anorexia nervosa, restricting type, in remissionF50.019 Anorexia nervosa, restricting type, unspecifiedF50.020 Anorexia nervosa, binge eating/purging type, mildF50.021 Anorexia nervosa, binge eating/purging type, moderateF50.022 Anorexia nervosa, binge eating/purging type, severeF50.023 Anorexia nervosa, binge eating/purging type, extremeF50.024 Anorexia nervosa, binge eating/purging type, in remissionF50.029 Anorexia nervosa, binge eating/purging type, unspecifiedF50.20 Bulimia nervosa, unspecifiedF50.21 Bulimia nervosa, mildF50.22 Bulimia nervosa, moderateF50.23 Bulimia nervosa, severeF50.24 Bulimia nervosa, extremeF50.25 Bulimia nervosa, in remissionF50.810 Binge eating disorder, mildF50.811 Binge eating disorder, moderateF50.812 Binge eating disorder, severeF50.813 Binge eating disorder, extremeF50.814 Binge eating disorder, in remissionF50.819 Binge eating disorder, unspecifiedF50.83 Pica in adultsF50.84 Rumination disorder in adultsG40.84 KCNQ2-related epilepsyG40.841 KCNQ2-related epilepsy, not intractable, with status epilepticusG40.842 KCNQ2-related epilepsy, not intractable, without status epilepticusG40.843 KCNQ2-related epilepsy, intractable, with status epilepticusG40.844 KCNQ2-related epilepsy, intractable, without status epilepticusG90.81 Serotonin syndromeG90.89 Other disorders of autonomic nervous systemG93.45 Developmental and epileptic encephalopathyI26.03 Cement embolism of pulmonary artery with acute cor pulmonaleI26.04 Fat embolism of pulmonary artery with acute cor pulmonaleI26.95 Cement embolism of pulmonary artery without acute cor pulmonaleI26.96 Fat embolism of pulmonary artery without acute cor pulmonaleJ34.82 Nasal valve collapseJ34.820 Internal nasal valve collapseJ34.8200 Internal nasal valve collapse, unspecifiedJ34.8201 Internal nasal valve collapse, staticJ34.8202 Internal nasal valve collapse, dynamicJ34.821 External nasal valve collapseJ34.8210 External nasal valve collapse, unspecifiedJ34.8211 External nasal valve collapse, staticJ34.8212 External nasal valve collapse, dynamicJ34.829 Nasal valve collapse, unspecifiedK60.30 Anal fistula, unspecifiedK60.31 Anal fistula, simpleK60.311 Anal fistula, simple, initialK60.312 Anal fistula, simple, persistentK60.313 Anal fistula, simple, recurrentK60.319 Anal fistula, simple, unspecifiedK60.32 Anal fistula, complexK60.321 Anal fistula, complex, initialK60.322 Anal fistula, complex, persistentK60.323 Anal fistula, complex, recurrentK60.329 Anal fistula, complex, unspecifiedK60.40 Rectal fistula, unspecifiedK60.41 Rectal fistula, simpleK60.411 Rectal fistula, simple, initialK60.412 Rectal fistula, simple, persistentK60.413 Rectal fistula, simple, recurrentK60.419 Rectal fistula, simple, unspecifiedK60.42 Rectal fistula, complexK60.421 Rectal fistula, complex, initialK60.422 Rectal fistula, complex, persistentK60.423 Rectal fistula, complex, recurrentK60.429 Rectal fistula, complex, unspecifiedK60.50 Anorectal fistula, unspecifiedK60.51 Anorectal fistula, simpleK60.511 Anorectal fistula, simple, initialK60.512 Anorectal fistula, simple, persistentK60.513 Anorectal fistula, simple, recurrentK60.519 Anorectal fistula, simple, unspecifiedK60.52 Anorectal fistula, complexK60.521 Anorectal fistula, complex, initialK60.522 Anorectal fistula, complex, persistentK60.523 Anorectal fistula, complex, recurrentK60.529 Anorectal fistula, complex, unspecifiedL29.81 Cholestatic pruritusL29.89 Other pruritusL66.10 Lichen planopilaris, unspecifiedL66.11 Classic lichen planopilarisL66.12 Frontal fibrosing alopeciaL66.19 Other lichen planopilarisL66.81 Central centrifugal cicatricial alopeciaL66.89 Other cicatricial alopeciaM51.360 Other intervertebral disc degeneration, lumbar region with discogenic back pain onlyM51.361 Other intervertebral disc degeneration, lumbar region with lower extremity pain onlyM51.362 Other intervertebral disc degeneration, lumbar region with discogenic back pain and lower extremity painM51.369 Other intervertebral disc degeneration, lumbar region without mention of lumbar back pain or lower extremity painM51.370 Other intervertebral disc degeneration, lumbosacral region with discogenic back pain onlyM51.371 Other intervertebral disc degeneration, lumbosacral region with lower extremity pain onlyM51.372 Other intervertebral disc degeneration, lumbosacral region with discogenic back pain and lower extremity painM51.379 Other intervertebral disc degeneration, lumbosacral region without mention of lumbar back pain or lower extremity painM62.85 Dysfunction of the multifidus muscles, lumbar regionM65.90 Unspecified synovitis and tenosynovitis, unspecified siteM65.91 Unspecified synovitis and tenosynovitis, shoulderM65.911 Unspecified synovitis and tenosynovitis, right shoulderM65.912 Unspecified synovitis and tenosynovitis, left shoulderM65.919 Unspecified synovitis and tenosynovitis, unspecified shoulderM65.92 Unspecified synovitis and tenosynovitis, upper armM65.921 Unspecified synovitis and tenosynovitis, right upper armM65.922 Unspecified synovitis and tenosynovitis, left upper armM65.929 Unspecified synovitis and tenosynovitis, unspecified upper armM65.93 Unspecified synovitis and tenosynovitis, forearmM65.931 Unspecified synovitis and tenosynovitis, right forearmM65.932 Unspecified synovitis and tenosynovitis, left forearmM65.939 Unspecified synovitis and tenosynovitis, unspecified forearmM65.94 Unspecified synovitis and tenosynovitis, handM65.941 Unspecified synovitis and tenosynovitis, right handM65.942 Unspecified synovitis and tenosynovitis, left handM65.949 Unspecified synovitis and tenosynovitis, unspecified handM65.95 Unspecified synovitis and tenosynovitis, thighM65.951 Unspecified synovitis and tenosynovitis, right thighM65.952 Unspecified synovitis and tenosynovitis, left thighM65.959 Unspecified synovitis and tenosynovitis, unspecified thighM65.96 Unspecified synovitis and tenosynovitis, lower legM65.961 Unspecified synovitis and tenosynovitis, right lower legM65.962 Unspecified synovitis and tenosynovitis, left lower legM65.969 Unspecified synovitis and tenosynovitis, unspecified lower legM65.97 Unspecified synovitis and tenosynovitis, ankle and footM65.971 Unspecified synovitis and tenosynovitis, right ankle and footM65.972 Unspecified synovitis and tenosynovitis, left ankle and footM65.979 Unspecified synovitis and tenosynovitis, unspecified ankle and footM65.98 Unspecified synovitis and tenosynovitis, other siteM65.99 Unspecified synovitis and tenosynovitis, multiple sitesQ23.81 Bicuspid aortic valveQ23.82 Congenital mitral valve cleft leafletQ23.88 Other congenital malformations of aortic and mitral valvesQ87.86 Kleefstra syndromeR41.85 AnosognosiaT45.A Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugsT45.AX Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugsT45.AX1 Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional)T45.AX1A Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounterT45.AX1D Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounterT45.AX1S Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequelaT45.AX2 Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harmT45.AX2A Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounterT45.AX2D Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounterT45.AX2S Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequelaT45.AX3 Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assaultT45.AX3A Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounterT45.AX3D Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounterT45.AX3S Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequelaT45.AX4 Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undeterminedT45.AX4A Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounterT45.AX4D Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounterT45.AX4S Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequelaT45.AX5 Adverse effect of immune checkpoint inhibitors and immunostimulant drugsT45.AX5A Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounterT45.AX5D Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounterT45.AX5S Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequelaT45.AX6 Underdosing of immune checkpoint inhibitors and immunostimulant drugsT45.AX6A Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounterT45.AX6D Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounterT45.AX6S Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequelaT81.320 Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closureT81.320A Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, initial encounterT81.320D Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, subsequent encounterT81.320S Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, sequelaT81.321 Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fasciaT81.321A Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, initial encounterT81.321D Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, subsequent encounterT81.321S Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, sequelaT81.328 Disruption or dehiscence of closure of other specified internal operation (surgical) woundT81.328A Disruption or dehiscence of closure of other specified internal operation (surgical) wound, initial encounterT81.328D Disruption or dehiscence of closure of other specified internal operation (surgical) wound, subsequent encounterT81.328S Disruption or dehiscence of closure of other specified internal operation (surgical) wound, sequelaT81.329 Deep disruption or dehiscence of operation wound, unspecifiedT81.329A Deep disruption or dehiscence of operation wound, unspecified, initial encounterT81.329D Deep disruption or dehiscence of operation wound, unspecified, subsequent encounterT81.329S Deep disruption or dehiscence of operation wound, unspecified, sequelaZ15.1 Genetic susceptibility to epilepsy and neurodevelopmental disordersZ15.2 Genetic susceptibility to obesityZ17.2 Progesterone receptor statusZ17.21 Progesterone receptor positive statusZ17.22 Progesterone receptor negative statusZ17.3 Human epidermal growth factor 2 receptorZ17.31 Human epidermal growth factor receptor 2 positive statusZ17.32 Human epidermal growth factor receptor 2 negative statusZ17.4 Combined receptor statusZ17.41 Hormone receptor positiveZ17.410 Hormone receptor positive with human epidermal growth factor receptor 2 positive statusZ17.411 Hormone receptor positive with human epidermal growth factor receptor 2 negative statusZ17.42 Hormone receptor negativeZ17.420 Hormone receptor negative with human epidermal growth factor receptor 2 positive statusZ17.421 Hormone receptor negative with human epidermal growth factor receptor 2 negative statusZ51.A Encounter for sepsis aftercareZ59.71 Insufficient health insurance coverageZ59.72 Insufficient welfare supportZ67.A Duffy phenotypeZ67.A1 Duffy nullZ67.A2 Duffy a positiveZ67.A3 Duffy b positiveZ67.A4 Duffy a and b positiveZ68.55 Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than 140% of the 95th percentile for ageZ68.56 Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile for ageZ83.72 Family history of familial adenomatous polyposisZ86.0100 Personal history of colon polyps, unspecifiedZ86.0101 Personal history of adenomatous and serrated colon polypsZ86.0102 Personal history of hyperplastic colon polypsZ86.0109 Personal history of other colon polypsZ92.26 Personal history of immune checkpoint inhibitor therapyT81.32XA Disruption of internal operation (surgical) wound, not elsewhere classified, initial encounterT81.32XD Disruption of internal operation (surgical) wound, not elsewhere classified, subsequent encounterT81.32XS Disruption of internal operation (surgical) wound, not elsewhere classified, sequelaA77.41 Ehrlichiosis chaffeensis [E. chaffeensis] (was: Ehrlichiosis chafeensis [E. chafeensis])F98.21 Rumination disorder of infancy and childhood (was: Rumination disorder of infancy)G93.42 Megalencephalic leukoencephalopathy with subcortical cysts (was: Megaloencephalic leukoencephalopathy with subcortical cysts)H44.2A3 Degenerative myopia with choroidal neovascularization, bilateral (was: Degenerative myopia with choroidal neovascularization, bilateral eye)H44.2B3 Degenerative myopia with macular hole, bilateral (was: Degenerative myopia with macular hole, bilateral eye)H44.2C3 Degenerative myopia with retinal detachment, bilateral (was: Degenerative myopia with retinal detachment, bilateral eye)H44.2D3 Degenerative myopia with foveoschisis, bilateral (was: Degenerative myopia with foveoschisis, bilateral eye)H44.2E3 Degenerative myopia with other maculopathy, bilateral (was: Degenerative myopia with other maculopathy, bilateral eye)I26.93 Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale (was: Single subsegmental pulmonary embolism without acute cor pulmonale)I26.94 Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale (was: Multiple subsegmental pulmonary emboli without acute cor pulmonale)K58.9 Irritable bowel syndrome, unspecified (was: Irritable bowel syndrome without diarrhea)Q13.81 Rieger anomaly (was: Rieger's anomaly)Z17 Estrogen, and other hormones and factors receptor status (was: Estrogen receptor status)Z68.54 Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the 95th percentile for age (was: Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age)Z86.010 Personal history of colon polyps (was: Personal history of colonic polyps)C83.39 Diffuse large B-cell lymphoma, extranodal and solid organ sites: now a non-billable headerC86.0 Extranodal NK/T-cell lymphoma, nasal type: now a non-billable headerC86.1 Hepatosplenic T-cell lymphoma: now a non-billable headerC86.2 Enteropathy-type (intestinal) T-cell lymphoma: now a non-billable headerC86.3 Subcutaneous panniculitis-like T-cell lymphoma: now a non-billable headerC86.4 Blastic NK-cell lymphoma: now a non-billable headerC86.5 Angioimmunoblastic T-cell lymphoma: now a non-billable headerC86.6 Primary cutaneous CD30-positive T-cell proliferations: now a non-billable headerC88.0 Waldenstrom macroglobulinemia: now a non-billable headerC88.2 Heavy chain disease: now a non-billable headerC88.3 Immunoproliferative small intestinal disease: now a non-billable headerC88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]: now a non-billable headerC88.8 Other malignant immunoproliferative diseases: now a non-billable headerC88.9 Malignant immunoproliferative disease, unspecified: now a non-billable headerE34.0 Carcinoid syndrome: now a non-billable headerE66.8 Other obesity: now a non-billable headerF50.01 Anorexia nervosa, restricting type: now a non-billable headerF50.02 Anorexia nervosa, binge eating/purging type: now a non-billable headerF50.2 Bulimia nervosa: now a non-billable headerF50.81 Binge eating disorder: now a non-billable headerG90.8 Other disorders of autonomic nervous system: now a non-billable headerK60.3 Anal fistula: now a non-billable headerK60.4 Rectal fistula: now a non-billable headerK60.5 Anorectal fistula: now a non-billable headerL29.8 Other pruritus: now a non-billable headerL66.1 Lichen planopilaris: now a non-billable headerL66.8 Other cicatricial alopecia: now a non-billable headerM51.36 Other intervertebral disc degeneration, lumbar region: now a non-billable headerM51.37 Other intervertebral disc degeneration, lumbosacral region: now a non-billable headerM65.9 Synovitis and tenosynovitis, unspecified: now a non-billable headerQ23.8 Other congenital malformations of aortic and mitral valves: now a non-billable headerZ59.7 Insufficient social insurance and welfare support: now a non-billable headerZ86.010 Personal history of colon polyps: now a non-billable header